Corbus Pharmaceuticals Holdings, Inc. (CRBP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - Corbus Pharmaceuticals is presenting at the 44th Annual JPMorgan Healthcare Conference, focusing on key assets and upcoming milestones [1][2] Group 1: Upcoming Milestones - The company plans to highlight important milestones for its ADC (Antibody-Drug Conjugate) this year [2] - A significant focus will be on the maturing data for CRB-701, particularly regarding its second-line monotherapy in head and neck cancer [3] Group 2: Data Presentation - Updated data on CRB-701 was presented at ESMO, indicating an increase in patient numbers and longer duration of response [3] - The company aims to present further maturing data at a large oncology conference later this year, emphasizing the duration of response for patients [4]